Allspring Global Investments
CORT icon

Allspring Global Investments’s Corcept Therapeutics CORT Stock Holding History

Allspring Global Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3M Buy
523,192
+308,620
+144% +$18.6M 0.07% 319
2026
Q1 		$9.01M Sell
214,572
-293,395
-58% -$11M 0.02% 721
2025
Q4 		$19.4M Buy
507,967
+268,155
+112% +$21.1M 0.03% 549
2025
Q3 		$20.2M Buy
239,812
+25,206
+12% +$1.82M 0.03% 544
2025
Q2 		$14.9M Sell
214,606
-13,406
-6% -$972K 0.02% 599
2025
Q1 		$21M Buy
228,012
+16,546
+8% +$1.01M 0.04% 504
2024
Q4 		$10.6M Sell
211,466
-39,602
-16% -$2.08M 0.02% 742
2024
Q3 		$11.6M Buy
251,068
+123,720
+97% +$4.4M 0.02% 719
2024
Q2 		$4.14M Buy
127,348
+541
+0.4% +$14.8K 0.01% 996
2024
Q1 		$3.19M Buy
126,807
+58,468
+86% +$1.38M 0.01% 1066
2023
Q4 		$2.22M Sell
68,339
-15,358
-18% -$422K ﹤0.01% 1152
2023
Q3 		$2.28M Buy
83,697
+65,148
+351% +$1.89M ﹤0.01% 1158
2023
Q2 		$413K Sell
18,549
-96,859
-84% -$2.23M ﹤0.01% 1607
2023
Q1 		$2.5M Sell
115,408
-25,120
-18% -$551K ﹤0.01% 1181
2022
Q4 		$2.85M Buy
140,528
+67,462
+92% +$1.69M ﹤0.01% 1142
2022
Q3 		$1.87M Buy
73,066
+57,775
+378% +$1.55M ﹤0.01% 1250
2022
Q2 		$363K Sell
15,291
-71,969
-82% -$1.57M ﹤0.01% 1659
2022
Q1 		$1.97M Sell
87,260
-2,815
-3% -$59.9K ﹤0.01% 1511
2021
Q4 		$1.78M Buy
+90,075
New +$1.83M ﹤0.01% 1603

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's CORT Position: Q2 2026 in Review

Allspring Global Investments increased its Corcept Therapeutics (CORT) stake by 144% in Q2 2026, buying an estimated $18.6M and bringing the position to 523,192 shares worth $46.3M. The position accounts for 0.07% of the portfolio, ranked #319.

Allspring Global Investments first reported a position in CORT in Q4 2021 and has held it in 19 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Allspring Global Investments held 523,192 shares of Corcept Therapeutics worth $46.3M as of Q2 2026.
  • Allspring Global Investments bought 308,620 Corcept Therapeutics shares in Q2 2026, an estimated $18.6M.
  • Corcept Therapeutics made up 0.07% of Allspring Global Investments's portfolio in Q2 2026, its #319 holding.
  • Allspring Global Investments first reported a position in Corcept Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.